Real-world adherence and persistence with medication among men with lower urinary tract symptoms owing to benign prostatic hyperplasia in Japan: a clinical prospective study
World Journal of Urology · 2025
DOI: 10.1007/s00345-025-05752-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift World Journal of Urology, 2025. Verfasst von Toshiyuki Kamoto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Miyazaki, Miyazaki, Japan. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Lower Urinary Tract Symptoms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: We investigated the persistence of medication for lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) and identified baseline factors associated with treatment discontinuation in a clinical cohort of Japanese men. METHODS: We included 2500 patients between April 1, 2014 and March 31, 2015. The final analysis included 2295 patients from 30 urological hospitals. We collected baseline characteristics, including age, prostate-specific antigen (PSA) level, prostate volume (PV), International Prostate Symptom Score (IPSS), and quality-of-life (QOL) score. The type of initial medication and reasons for treatment discontinuation were recorded. RESULTS: The median participant age was 72 years. The median PSA level was 2.4 ng/mL, the median PV was 33 mL, the median IPSS score was 15 points, and the median QOL score was 5 points. The median time to medication discontinuation was 154 days (95% confidence interval [CI]: 132-176). Persistence rates at 1, 2, 3, 4, and 5 years were 37.3%, 29.1%, 24.2%, 20.2%, and 17.8%, respectively. The most common reason for discontinuation was loss to follow-up (71.1%). Multivariate analysis showed that younger age (70-79 vs. ≥80 years and ≤ 69 vs. ≥80 years), higher PSA level (≥ 2.4 vs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University of Miyazaki, Miyazaki, Japan.
- Department of Urology, University of Miyazaki, Miyazaki, Japan. hiromasa_tsukino@med.miyazaki-u.ac.jp.
- Department of Urology, Junwakai Memorial Hospital, 1119 Komatsu, Miyazaki, Miyazaki, 880-2112, Japan. hiromasa_tsukino@med.miyazaki-u.ac.jp.
ORCID-Profile: Hiromasa Tsukino
Zitieren
APA
Kamoto, T., & Tsukino, H. (2025). Real-world adherence and persistence with medication among men with lower urinary tract symptoms owing to benign prostatic hyperplasia in Japan: a clinical prospective study. World Journal of Urology. https://doi.org/10.1007/s00345-025-05752-9
Vancouver
Kamoto T, Tsukino H. Real-world adherence and persistence with medication among men with lower urinary tract symptoms owing to benign prostatic hyperplasia in Japan: a clinical prospective study. World Journal of Urology. 2025. doi:10.1007/s00345-025-05752-9
BibTeX
@article{Kamoto2025,
author = {Kamoto, Toshiyuki and Tsukino, Hiromasa},
title = {Real-world adherence and persistence with medication among men with lower urinary tract symptoms owing to benign prostatic hyperplasia in Japan: a clinical prospective study},
journal = {World Journal of Urology},
year = {2025},
doi = {10.1007/s00345-025-05752-9}
}
EUVIMED